Status:

UNKNOWN

Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis

Lead Sponsor:

Beijing Chest Hospital

Conditions:

Tuberculous Meningitis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The genetically polymorphic N-acetyltransferase type 2 (NAT2) is responsible for isoniazid metabolism, and rapid acetylators were associated with low concentrations of isoniazid based on previous stud...

Detailed Description

Tuberculous meningitis (TBM) is the most lethal form of tuberculosis, causing death or severe neurologic deficits in more than half of those affected in spite of antituberculosis chemotherapy. Among t...

Eligibility Criteria

Inclusion

  • 18 to 65 years of age;
  • Clinical diagnosis of TBM;
  • Able and willing to provide informed consent to participate in the study.

Exclusion

  • Using any other second line antituberculosis drug;
  • Received anti-tuberculosis therapy in the past 3 years;
  • Positive CSF Gram or India ink stain;
  • Received more than 14 days of anti-tuberculosis drugs for the current infection;
  • Known or suspected hypersensitivity to or unacceptable side effects from any oral first line antituberculosis drug;
  • Plasma creatinine concentration was more than the upper limit of the normal range, or the plasma bilirubin concentration was more than 2 times the upper limit of the normal range, or the plasma alanine aminotransferase level was more than three times the upper limit of the normal range;
  • Known or suspected pregnancy;
  • Known or suspected isoniazid and/or rifampin resistant;
  • Lack of consent;
  • Any participant for whom investigators judge this study is not appropriate.

Key Trial Info

Start Date :

March 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

676 Patients enrolled

Trial Details

Trial ID

NCT03787940

Start Date

March 4 2019

End Date

December 31 2021

Last Update

February 1 2021

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Beijing Chest Hospital affiliated to Capital Medical University

Beijing, China

2

Jiamusi Infectious Disease Hospital

Jiamusi, China

3

Jiangxi Provincial Chest Hospital

Nanchang, China

4

Zunyi Medical College affiliated Hospital

Zunyi, China